SIGLEC-4 (MAG) Antagonists: From the Natural Carbohydrate Epitope to Glycomimetics
The DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index.
Abstract
Siglec-4, also known as myelin-associated glycoprotein (MAG), is a member of the siglec (sialic acid-binding immunoglobulin-like lectins) family. MAG binds with high preference to sialic acids α(2-3)-linked to D-galactose. Although the involvement and relevance of its sialic acid binding activity is still controversial, it could be demonstrated that interactions of MAG with sialylated gangliosides play an important role in axon stability and regeneration. In this article we describe in detail our current understanding of the biological role and the carbohydrate specificity of siglec-4. Furthermore, this review compiles the intensive research efforts leading from the identification of the minimal oligosaccharide binding epitope in gangliosides via micromolar oligosaccharide mimics to the development of small molecular weight and more drug-like sialic acid derivatives binding with low nanomolar affinities. Such compounds will be useful to elucidate MAG's biological functions, which are currently not fully understood.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the role of Myelin-associated glycoprotein (MAG, Siglec-4) in mediating key interactions between neurons and glia (930 -932), a process critical for maintaining the stability of the myelin sheath that insulates axons (933 -934).”
From Biological roles of glycans (2017) · cites this paper as [932]
Citations
Cites
p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure
Hansch, C., & Fujita, T. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a035 · Cited by 2,313
Drug-target residence time and its implications for lead optimization
Copeland, R. A., Pompliano, D. L., & Meek, T. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2082 · Cited by 1,464
Métézeau, P. (1998) · Research in Microbiology · doi:10.1016/s0923-2508(98)80442-7 · Cited by 1,243
McKerracher, L., David, S., Jackson, D. L., Kottis, V., Dunn, R. J., & Braun, P. E. (1994) · Neuron · doi:10.1016/0896-6273(94)90247-x · Cited by 1,126
A decade of fragment-based drug design: strategic advances and lessons learned
Hajduk, P. J., & Greer, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2220 · Cited by 1,064
A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration
Mukhopadhyay, G., Doherty, P., Walsh, F. S., Crocker, P. R., & Filbin, M. T. (1994) · Neuron · doi:10.1016/0896-6273(94)90042-6 · Cited by 1,061
The rise of fragment-based drug discovery
Murray, C. W., & Rees, D. C. (2009) · Nature Chemistry · doi:10.1038/nchem.217 · Cited by 791
Lewis, W. G., Green, L. G., Grynszpan, F., Radić, Z., Carlier, P. R., Taylor, P., Finn, M. G., & Sharpless, K. B. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020315)41:6<1053::aid-anie1053>3.0.co;2-4 · Cited by 744
Kruse, J., Mailhammer, R., Wernecke, H., Faissner, A., Sommer, I., Goridis, C., & Schachner, M. (1984) · Nature · doi:10.1038/311153a0 · Cited by 713
Advances in surface plasmon resonance biosensor analysis
Rich, R. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00054-3 · Cited by 665
Research works printed but not linked: 2
- Ito H, Ishida H, Kiso M, Hasegawa A (1998) Carbohydr Res 306:581–585
- Swinney DJ (2008) PharmMed 22:23–34
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
Sialic Acid Mimetics to Target the Sialic Acid–Siglec Axis
Büll, C., Heise, T., Adema, G. J., & Boltje, T. J. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.03.007 · Cited by 165
Gonzalez-Gil, A., & Schnaar, R. L. (2021) · Cells · doi:10.3390/cells10051260 · Cited by 131
“Structures with bound minimal sialoglycan ligands, each with the sialic acid carboxylate liganded to a conserved arginine residue, provide the basis for designing enhanced sialomimetics, sialosides synthetically modified with unnatural chemical substituents to engage amino acids near the primary sialic acid binding si…”
BackgroundTherapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches
Angata, T., Nycholat, C. M., & Macauley, M. S. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.06.008 · Cited by 109
Lectin antagonists in infection, immunity, and inflammation
Meiers, J., Siebs, E., Zahorska, E., & Titz, A. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.07.005 · Cited by 67
Structural advances of Siglecs: insight into synthetic glycan ligands for immunomodulation
Movsisyan, L. D., & Macauley, M. S. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/d0ob01116a · Cited by 42
Advanced Technologies in Sialic Acid and Sialoglycoconjugate Analysis
Kitajima, K., Varki, N. M., & Sato, C. (2013) · Topics in current chemistry · doi:10.1007/128_2013_458 · Cited by 26
Zhang, H., Xie, Y.-F., Hu, Z., Yu, H., Xie, X., Ye, Y., Xu, W., Nian, S., & Yuan, Q. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.608113 · Cited by 26
“This result seems reasonable, since MAG, in contrast to other SIGLECs, appears to be solely expressed in myelin oligodendrocytes and Schwann cells but not in human immune cells and does not carry any immunoreceptor tyrosine-based inhibitory motifs (84).”
ResultSialic Acid as a Target for the Development of Novel Antiangiogenic Strategies
Chiodelli, P., Urbinati, C., Paiardi, G., Monti, E., & Rusnati, M. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0298 · Cited by 20
Novel approaches to glycomimetic design: development of small molecular weight lectin antagonists
Damalanka, V. C., Maddirala, A. R., & Janetka, J. W. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1857721 · Cited by 17
Computational Docking as a Tool for the Rational Design of Carbohydrate-Based Drugs
Frank, M. (2014) · Topics in medicinal chemistry · doi:10.1007/7355_2014_42 · Cited by 10
Tetra‐ and Hexavalent Siglec‐8 Ligands Modulate Immune Cell Activation
Conti, G., Bärenwaldt, A., Rabbani, S., Mühlethaler, T., Sarcevic, M., Jiang, X., Schwardt, O., Ricklin, D., Pieters, R. J., Laubli, H. P., et al. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202314280 · Cited by 7
Self-citationN-Glycan–Dependent Proinflammatory Effects of IgM in Anti-MAG Neuropathy
Neil, J., Fenaille, F., Bruneel, A., Stojkovic, T., Cholet, S., Delmont, É., Ober, P., Raynor, A., Amiot, Q., Dorgham, K., et al. (2025) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200440 · Cited by 1
Tetra‐ and Hexavalent Siglec‐8 Ligands Modulate Immune Cell Activation
Conti, G., Bärenwaldt, A., Rabbani, S., Mühlethaler, T., Sarcevic, M., Jiang, X., Schwardt, O., Ricklin, D., Pieters, R. J., Laubli, H. P., et al. (2023) · Angewandte Chemie · doi:10.1002/ange.202314280
Self-citation
Metadata
- Authors
- Schwardt, O., Kelm, S., & Ernst, B.
- Affiliations
- University of Basel (CH)
- Corresponding author
- Ernst, Beat
- Venue
- Topics in current chemistry
- Publisher
- Springer International Publishing
- Published
- 2013
- Volume
- 367
- Pages
- 151-200
- ISSN
- 0340-1022 (ISSN-L)
- 1436-5049
- OpenAlex
- W1267130681
- Cited by
- 14
- References
- 115
- Citations by year
- 2025: 1 · 2023: 2 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 1 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 1
- FWCI
- 2.18
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Topics in current chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- Keywords
- myelin-associated glycoprotein, sialic acid binding, carbohydrate mimetics, oligosaccharide mimetics, carbohydrate epitopes, sialic acid derivatives, axon regeneration, sialic acid-binding immunoglobulin-like lectins
- MeSH terms
- Amino Acid Sequence, Epitopes, Carbohydrate Sequence, Gangliosides, Humans, Molecular Sequence Data, Oligosaccharides, Protein Binding, Sialic Acids, Structure-Activity Relationship, Sequence Homology, Amino Acid, Molecular Mimicry, Myelin-Associated Glycoprotein, Biomimetics, Glycomics, Small Molecule Libraries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.